Market Closed

SYRE
Spyre Therapeutics
$ 104.00
1.06%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago

Spyre Therapeutics News

Latest Spyre Therapeutics Stock News & SYRE Headlines

Spyre Therapeutics Announces Grants of Inducement Awards
9 days ago | globenewswire.com
Spyre Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
12 days ago | globenewswire.com
Spyre Therapeutics Announces Clinical and Preclinical Data Presentations at United European Gastroenterology Week (UEGW) 2026
a month ago | globenewswire.com
Spyre Therapeutics Announces Pricing of $350.0 Million Public Offering of Common Stock
a month ago | globenewswire.com
Spyre Therapeutics Announces Proposed Public Offering of its Common Stock
a month ago | globenewswire.com
Spyre (NASDAQ: SYRE) legal chief trims stake in planned share sale
a month ago | defenseworld.net
Spyre Therapeutics Announces Grants of Inducement Awards
a month ago | globenewswire.com
Spyre Therapeutics (NASDAQ:SYRE) Shares Gap Up – Should You Buy?
a month ago | defenseworld.net
California State Teachers Retirement System Buys 5,683,670 Shares of Spyre Therapeutics, Inc. $SYRE
2 months ago | defenseworld.net
11,250 Shares in Spyre Therapeutics, Inc. $SYRE Acquired by VIRGINIA RETIREMENT SYSTEMS ET Al
2 months ago | defenseworld.net
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

SYRE
Spyre Therapeutics
$ 104.00
1.06%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago